Top Stories
Reuters
Updated On Aug 8, 2023 at 04:53 AM IST
The World Health Organization (WHO) issued a warning on Monday regarding a batch of common cold syrup that has been found to be contaminated. The syrup, known as Cold Out, was manufactured by Fourrts (India) Laboratories for Dabilife Pharma and was discovered in Iraq. The contamination includes higher than acceptable levels of diethylene and ethylene glycol.
The WHO's medical product alert states that this batch of Cold Out contained 0.25% diethylene glycol and 2.1% ethylene glycol, surpassing the allowable safety limit of 0.10%. Notably, neither the manufacturer nor the marketer has provided assurances to the WHO regarding the product's safety and quality.
Responses from the involved companies, Fourrts (India) Laboratories and Dabilife Pharma, were not available for comment at the time of Reuters' inquiries made outside of regular business hours.
This incident marks the latest in a series of warnings from the WHO concerning contaminated cough syrups sold globally, with a significant number of them linked to Indian manufacturers. The issue of contaminated cough syrups from India has even resulted in fatalities, including the deaths of 89 children in Gambia and Uzbekistan last year. In response, Indian authorities took action against certain manufacturers, such as Riemann Labs, whose cough syrup was linked to child deaths in Cameroon.
Marion Biotech, a company whose syrups were exported to Uzbekistan, had its manufacturing license revoked by Indian regulators, and some of its employees were arrested. Maiden Pharmaceuticals, another company involved in the case, denied responsibility for the deaths in Gambia. Indian government laboratory tests did not detect toxins in their products.
New COVID-19 Subvariants Spread Rapidly but Cause Mild Illness, Say Doctors
Doctors Successfully Remove Wooden Piece from 12-Year-Old Boy's Chest
നീറ്റ് എം.ഡി.എസ് പ്രവേശന പരീക്ഷ 2024 മാർച്ചിലേക്ക് മാറ്റി നാഷണൽ ബോർഡ് ഓഫ് എക്സാമിനേഷൻസ് (എൻ.ബി.ഇ). ഏറ്റവും പുതിയ വിവരം അനുസരിച്ച്, നീറ്റ് എം.ഡി.എസ് 2024 പരീക്ഷാ തീയതി മാർച്ച് 18-ന് ആണ് നിശ്ച്ചയിച്ചിരിക്കുന്നത്. നീറ്റ് എം.
In a landmark achievement, doctors at the Jaslok Hospital and Research Centre in Mumbai announced the successful Total Knee Replacement (TKR) procedure on a 72-year-old American man, weighing a remarkable 193 kg. This groundbreaking surgery marks a significant milestone as the heaviest patient ever to undergo such a procedure globally. TKR stands as a transformative intervention for individuals grappling with excruciating knee pain, offering them renewed mobility and an improved quality of life. However, for overweight individuals, accessing this treatment presents formidable challenges due to heightened surgical risks and technical intricacies.
According to the surgical team, led by Dr. Rajesh Nawalkar, Senior Consultant in Orthopaedics, every patient's unique circumstances demand a tailored approach to surgery. By meticulously customizing their techniques and collaborating closely with fellow medical professionals, they successfully navigated the complexities posed by the patient's weight, culminating in a triumphant outcome. Among the foremost hurdles encountered in TKR for overweight patients are the elevated risks associated with anesthesia and the heightened potential for embolism. This underscores the importance of precision and vigilance in addressing the specific needs of each patient to ensure optimal results and minimize complications.
Furthermore, the conventional use of a tourniquet, a standard protocol in TKR surgeries, presents technical challenges due to the patient's larger thigh circumference, heightening the risk of tissue damage and post-operative complications. In response to these challenges, Dr. Nawalkar collaborated closely with instrument manufacturers to devise specialized instruments tailored to accommodate the patient's unique anatomy, thereby ensuring optimal surgical outcomes. Additionally, meticulous preoperative assessments and consultations were conducted to ascertain the patient's readiness and obtain informed consent.
Richard Koszarek, the patient, underwent the surgery on January 7, 2024, with no reported complications during the procedure. However, the path to recovery was equally crucial, with rehabilitation playing a pivotal role in achieving successful outcomes. Despite facing reluctance from numerous doctors in India and abroad due to his weight, Richard expressed gratitude to the surgical team for their unwavering commitment and skillful intervention, which enabled him to regain mobility and resume an active lifestyle.
The junior doctors at Veer Surendra Sai Institute of Medical Science And Research (VIMSAR) are threatening to go on a cease-work strike due to pending stipends and other irregularities, potentially stalling healthcare services.
We have various options to advertise with us including Events, Advertorials, Banners, Mailers, etc.
